BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23026704)

  • 1. Is amyotrophic lateral sclerosis a primary astrocytic disease?
    Sica RE
    Med Hypotheses; 2012 Dec; 79(6):819-22. PubMed ID: 23026704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amyotrophic lateral sclerosis: is the astrocyte the cell primarily involved?].
    Sica RE
    Medicina (B Aires); 2013; 73(6):573-8. PubMed ID: 24356272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective overexpression of gamma1 laminin in astrocytes in amyotrophic lateral sclerosis indicates an involvement in ALS pathology.
    Wiksten M; Väänänen A; Liesi P
    J Neurosci Res; 2007 Jul; 85(9):2045-58. PubMed ID: 17554784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The causes and mechanism of selective motor neuron death in amyotrophic lateral sclerosis].
    Van den Bosch L
    Verh K Acad Geneeskd Belg; 2006; 68(4):249-69. PubMed ID: 17214440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent cleavage and nuclear translocation of apoptosis-inducing factor in motor neurons in the spinal cord of sporadic amyotrophic lateral sclerosis patients.
    Shibata N; Kakita A; Takahashi H; Ihara Y; Nobukuni K; Fujimura H; Sakoda S; Sasaki S; Yamamoto T; Kobayashi M
    Acta Neuropathol; 2009 Dec; 118(6):755-62. PubMed ID: 19669652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum stress in motor neurons of the spinal cord in sporadic amyotrophic lateral sclerosis.
    Sasaki S
    J Neuropathol Exp Neurol; 2010 Apr; 69(4):346-55. PubMed ID: 20448480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between astrocytes and motor neurons: what is the message?
    Van Den Bosch L; Robberecht W
    Exp Neurol; 2008 May; 211(1):1-6. PubMed ID: 18291372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excitotoxicity and amyotrophic lateral sclerosis.
    Van Damme P; Dewil M; Robberecht W; Van Den Bosch L
    Neurodegener Dis; 2005; 2(3-4):147-59. PubMed ID: 16909020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients.
    Calingasan NY; Chen J; Kiaei M; Beal MF
    Neurobiol Dis; 2005; 19(1-2):340-7. PubMed ID: 15837590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Shobha K; Vijayalakshmi K; Alladi PA; Nalini A; Sathyaprabha TN; Raju TR
    J Neurol Sci; 2007 Mar; 254(1-2):9-16. PubMed ID: 17254611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic mechanisms in amyotrophic lateral sclerosis.
    Sandyk R
    Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis.
    Cutler RG; Pedersen WA; Camandola S; Rothstein JD; Mattson MP
    Ann Neurol; 2002 Oct; 52(4):448-57. PubMed ID: 12325074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
    Heath PR; Shaw PJ
    Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium dysregulation in amyotrophic lateral sclerosis.
    Grosskreutz J; Van Den Bosch L; Keller BU
    Cell Calcium; 2010 Feb; 47(2):165-74. PubMed ID: 20116097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis.
    Drachman DB; Rothstein JD
    Ann Neurol; 2000 Nov; 48(5):792-5. PubMed ID: 11079544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyotrophic lateral sclerosis.
    Gordon PH; Mitsumoto H; Hays AP
    Sci Aging Knowledge Environ; 2003 Sep; 2003(35):dn2. PubMed ID: 12954882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyotrophic lateral sclerosis and Alzheimer disease. Lessons from model systems.
    Price DL; Wong PC; Borchelt DR; Pardo CA; Thinakaran G; Doan AP; Lee MK; Martin LJ; Sisodia SS
    Rev Neurol (Paris); 1997 Sep; 153(8-9):484-95. PubMed ID: 9683997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pigmented creatine deposits in Amyotrophic Lateral Sclerosis central nervous system tissues identified by synchrotron Fourier Transform Infrared microspectroscopy and X-ray fluorescence spectromicroscopy.
    Kastyak MZ; Szczerbowska-Boruchowska M; Adamek D; Tomik B; Lankosz M; Gough KM
    Neuroscience; 2010 Apr; 166(4):1119-28. PubMed ID: 20097271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined excitotoxic-oxidative stress and the concept of non-cell autonomous pathology of ALS: insights into motoneuron axonopathy and astrogliosis.
    Wallis N; Zagami CJ; Beart PM; O'Shea RD
    Neurochem Int; 2012 Sep; 61(4):523-30. PubMed ID: 22421531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two autopsy cases of sporadic amyotrophic lateral sclerosis with 20-year-clinical course without respirators].
    Kato S; Oda M; Hayashi H; Komori T; Hirose K; Tanabe H; Arai N
    No To Shinkei; 1993 Mar; 45(3):267-72. PubMed ID: 8323821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.